Kyntra Bio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$4.85-$12.60
Market Cap
$27.4M
Shares Short
113,096

Financials

See more
Revenue (12 Mos)
$6.4M
Revenue Growth (YoY)
-59.3%
Gross Profit (12 Mos)
-$17.6M
Diluted EPS
-$14.40

News

See more

Yahoo Finance • last month

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

About

CEO
Mr. Thane Wettig
CFO
Mr. David DeLucia
Address
350 Bay Street, San Francisco, CA, United States, 94133
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
34